A review of obesity medications published in JAMA found that: Qsymia was associated with 8% more weight loss than placebo in five randomized controlled trials that included 3,407 participants
PlexusDx provides compounded semaglutide ($189/mo), oral semaglutide ($289/mo), compounded tirzepatide ($289/mo), and specialty combinations like Microdose GLP-1 and GLP-Squared
Insurance coverage remains inconsistent and unpredictable
Furthermore, as real users have reported, it promotes energy levels, potentially leading to a more active lifestyle
Research has shown that GLP-1, along with other gut-brain peptides like ghrelin, leptin, and galanin, acts on the mesolimbic dopamine system of the brain and influences the activation of this system by alcohol and other addictive drugs